

http://allafrica.com/stories/201611220152.html
http://www.fool.com/investing/2016/11/21/13-billion-opportunity-5-companies-that-could-domi.aspx?source=eptfxblnk0000004&utm_campaign=article&utm_medium=feed&utm_source=foxbusiness
http://www.fool.com/investing/2016/11/21/13-billion-opportunity-5-companies-that-could-domi.aspx
http://www.thecitizen.co.tz/News/Berlin-firm--Dar-unite-in-malaria-war/1840340-3459238-vjn75sz/index.html
http://www.wgmd.com/13-billion-opportunity-5-companies-that-could-dominate-the-alzheimer039s-disease-market/
http://www.dallasnews.com/business/health-care/2016/11/22/can-two-dose-hpv-vaccine-boost-adherence-lower-costs-texas
https://www.prlog.org/12603285-boston-massachusetts-to-host-4th-annual-pre-filled-syringes-east-coast-summit-in-april-2017.html
http://military-technologies.net/2016/11/22/biolinerx-reports-third-quarter-2016-financial-results/
http://www.bizjournals.com/boston/news/2016/11/22/south-bostons-intarcia-aims-to-double-in-size-for.html
http://www.fool.com/investing/2016/11/21/attention-biotech-investors-black-friday-is-alread.aspx
http://www.proactiveinvestors.co.uk/columns/guardian-cfds-pre-market-briefing/26561/market-briefing-us-markets-ended-lower-on-friday-amid-a-rally-in-the-us-dollar-and-weakness-in-healthcare-stocks-26561.html
http://hamodia.com/2016/11/20/drugmaker-losses-pull-stocks-lower-small-cap-surge-goes/
http://www.irishtimes.com/business/health-pharma/case-study-how-clinical-trial-helped-one-cancer-patient-1.2875499
http://www.fool.com/investing/2016/11/22/what-happened-in-biotech-in-2016.aspx
http://www.upi.com/Health_News/2016/11/22/2-doses-of-HPV-vaccine-effective-for-younger-teens/9391479849927/
http://www.medicalnewstoday.com/releases/314281.php
http://www.wgmd.com/fda-outlines-data-needed-for-over-the-counter-sunscreen-additives/
http://news.trust.org/item/20161122165905-kc4x3/

http://www.cnbc.com/2016/11/21/what-trump-isnt-saying-about-drugmakers-matters.html


http://www.manufacturingchemist.com/jobs/article_page/Management_team_strengthened_as_Auspherix_drives_new_class_of_antibacterials_towards_the_clinic/123131
https://www.yahoo.com/news/astrazeneca-cleared-resume-enrolment-cancer-085605853.html
http://www.proactiveinvestors.co.uk/companies/news/169322/astrazeneca-restarts-cancer-drug-trials-after-us-all-clear-169322.html
http://www.startribune.com/trump-goes-quiet-on-curbing-drug-costs/402351925/
http://www.prnewswire.com/news-releases/antibacterial-drugs-world-industry-and-market-prospects-2016-2026-300366982.html
http://military-technologies.net/2016/11/21/worldwide-antifungal-market-2016-industry-analysis-outlook-2020-forecasts/
http://politi.co/2gb78JY
https://www.eurekalert.org/pub_releases/2016-11/tjnj-sci111816.php
http://military-technologies.net/2016/11/21/adult-and-adolescent-vaccines-market-revenue-predicted-to-go-up-by-2021-persistence-market-research-report/
http://www.claimsjournal.com/news/national/2016/11/21/275077.htm
http://www.bendbulletin.com/nation/4835280-151/drugmakers-help-trump-shape-health-care-agenda
http://www.foxnews.com/health/2016/11/22/fda-outlines-data-needed-for-over-counter-sunscreen-additives.html
http://www.manufacturingchemist.com/news/article_page/Cancer_vaccines_market_will_soar_to_75_billion_by_2022_says_GBI_Research/123151
